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ABSTRACT: This paper reports a novel design of a
miniaturized three-electrode electrochemical cell, the purpose
of which is aimed at generating drug metabolites with a high
conversion eﬃciency. The working electrode and the counter
electrode are placed in two separate channels to isolate the
reaction products generated at both electrodes. The novel
design includes connecting channels between these two
electrode channels to provide a uniform distribution of the
current density over the entire working electrode. In addition,
the eﬀect of ohmic drop is decreased. Moreover, two ﬂow
resistors are included to ensure an equal ﬂow of analyte through both electrode channels. Total conversion of fast reacting ions is
achieved at ﬂow rates up to at least 8 μL/min, while the internal chip volume is only 175 nL. Using this electrochemical chip, the
metabolism of mitoxantrone is studied by microchip electrospray ionization−mass spectrometry. At an oxidation potential of 700
mV, all known metabolites from direct oxidation are observed. The electrochemical chip performs equally well, compared to a
commercially available cell, but at a 30-fold lower ﬂow of reagents.
In the past few decades, costs to develop a new drug,accepted by the U.S. Food and Drug Administration (FDA),
have grown exponentially, to an estimated 802−1318 million
dollars.1 FDA approval is important, since the United States is,
by far, the largest of all of the international markets. The typical
workﬂow of drug screening starts with years of extensive
preclinical research.2 In this preclinical research, often large
numbers of molecules are tested with the goal of identifying the
most promising candidate. These in vitro tests often look at
binding to receptors, eﬀects on enzyme activities, toxic eﬀects,
or other in vitro parameters. For these in vitro tests, only small
amounts of the molecule are required. The next step in
preclinical trials involves larger volumes of promising
candidates, which are produced for animal model testing. In
the end, only one or very few compounds are selected for
further clinical trials. These clinical trials are conducted in
several phases to establish the safety for use in human subjects.
In this paper, we present an approach to use miniaturized
electrochemical cells to mimic the metabolism of drugs, aiming
to reduce the required amount of time and money involved
with the preclinical part of drug screening and to limit the
amount of animal testing to the absolute minimum.
One of the major enzyme families that play a role in how
drugs are processed in the human body is the cytochrome P450
(CYP450) superfamily. CYP450 enzymes are responsible for
the oxidative metabolism of ∼75% of the marketed drugs in
current clinical use.3−5 Understandably, the study of CYP450
metabolic reactions is one of the important steps in current
(preclinical) drug screening methods.
In general, four in vitro methods have been recognized to
mimic the in vivo CYP450 drug metabolism reactions.6 The
method that is easiest to compare to the in vivo situation is the
enzymatic model, which uses liver cell extracts. One of the
major drawbacks of this method is that metabolic products
might adhere to the cell membrane present in the liver cell
extracts, making them undetectable. A second model is based
on metalloporphyrin-containing systems.7 The idea behind this
second model is to mimic the reactive center of the haem group
present in the CYP450 enzyme, using a similar molecular
structure. The third model is based on the electrochemically
assisted Fenton reaction.6 This method can be regarded as a
chemical way of oxidizing organic compounds using hydroxyl
radicals. In the simplest approach, a Fenton reagent containing
hydrogen peroxide and a ferrous salt is mixed with an organic
compound to study the oxidation products. The simpliﬁed
Fenton reaction is as follows:
+ → + + •+ + −Fe H O Fe OH OH2 2 2 3 (1)
A more ingenious online Fenton method is presented by Jurva
et al.,8 where the Fe3+ cation is reduced in an online
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electrochemical ﬂow-through cell, such that the Fe ions are
recycled.
Perhaps the most obvious method to induce oxidation
reactions is to use direct electrochemical oxidation. In Table 1,
a comparison is shown of the reactions that are known to occur
in CYP450-based oxidation and direct electrochemical
oxidation.9−11 Most of the reactions observed by CYP450
catalysis are also observed using direct oxidation, except for
epoxidation, alcohol, and aldehyde oxidation reactions. The
method is shown to be feasible in numerous studies.9,10,12−32 A
good comparison of all four methods has been discussed in
several reviews and papers.9,6,11
Direct electrochemical oxidation is not the same as oxidation
by CYP450 (as illustrated in Table 1), but it can be used as
complementary tool. Direct oxidation oﬀers several advantages
over liver cell microsomal incubation. It is a low-cost method, it
can be done online in an automated fashion, and, therefore, it is
a fast method. Liver cell microsomal incubations are still
regarded as the gold standard; however, in some cases, direct
electrochemical oxidation is shown to give more information on
the generated metabolites.33
In a review by Baumann and Karst, an overview is given of
the electrochemical cell designs used for the generation of
oxidative metabolism products.11 Moreover, Prudent and
Girault reviewed modiﬁcations to electrospray ionization
(ESI) interfaces with the purpose to study electrochemical
conversions.34 The designs presented in these two reviews
include ﬂow-through cells with porous working electrodes,14,35
thin-layer cells where the analyte is ﬂushed in a thin layer over
the working electrode36−38 or cells where the electrospray
ionization interface is used as an electrochemical convert-
er.39−41 Macroscale ﬂow-through and thin-layer cells can be
bought commercially from companies such as Antec Leyden
and ESA.
In electrochemistry−ESI-based setups, a potential for
electrochemical conversions is applied between two conducting
tubes, connected with a piece of nonconducting tube. The tube
downstream is usually part of the ESI interface, and therefore
connected to the high-voltage power supply of the mass
spectrometer. A more-advanced version of this cell has been
shown by Xu et al.,39 which includes a commercial nonaqueous
(type MF-2062, BASi) Ag/Ag+ reference electrode and a
platinum wire as the working electrode. Fused-silica tubing acts
as a spacer between the working electrode and the counter
electrode. This counter electrode is composed of a larger tube
ﬁtted around the fused-silica tubing and acts simultaneously as
a tip for the ESI interface. The beneﬁt of using the ESI tip as an
electrochemical converter is that it opens up the possibility to
study shorter living compounds. However, generally, the
turnover rates are low. Moreover, care needs to be taken to
avoid the hazard of electric shock from the high-voltage power
supply of the ESI interface. Floating (and electrically well-
insulated) potentiostats might be required if the ESI tip is not
connected to the ground potential.
Miniaturized electrochemical cells in a lab-on-chip format
can provide speciﬁc advantages. Electrochemical reaction rates
are often limited by mass transport of ionic species. Because of
the small size, a lab-on-chip device might oﬀer speciﬁc
advantages to achieve a high conversion eﬃciency of
introduced products. Also, volumes are small, giving the
possibility to work with small amounts of products. Another
advantage is that miniaturized cells, when combined with tools
such as ESI−mass spectrometry (MS), can be used to study
short-living reactive intermediates. Moreover, lab-on-chip
devices can be used as low-cost disposables if produced in
suﬃcient quantities. Disposable devices also circumvent the
need for extensive cleaning procedures of the electrodes after
use.
Many of the miniaturized cells reported in the literature
consist of planar electrodes deposited on a substrate, covered
with another substrate containing microﬂuidic channels, inlets,
and outlets. This approach is demonstrated using various
substrates, such as glass/PDMS,42,43 PET,44 polyimide,45 and
Polystyrol.46 Alignment during the bonding of these two
substrates can be diﬃcult, especially if small electrodes are
considered.
Several other methods have been published for fabricating
miniaturized ﬂow-through cells. Probably one of the easier
methods is to use a piece of plexiglass, with drilled microﬂuidic
channels and inserted wires as electrodes.47,48 The drawback of
this approach is that the size of the microﬂuidic channels is
limited by the size of the drill. Therefore, the internal volumes
of those cells is generally quite large (on the scale of several
microliters to milliliters).
Another easy fabrication method comprises the use of
ﬂuorinated ethylene propylene (FEP, shrink tubing), which is
shrunk and simultaneously melted around a channel template
(a tungsten wire).49 Electrodes are melted into the FEP, either
perpendicular or parallel to the tungsten channel template.
Afterward, the tungsten wire is removed to open the channel.
The major drawback of this method is that it is not easy to
predict the area of the electrode that is in contact with the
electrolyte.
Liljegren et al. fabricated a ﬂow-through cell speciﬁcally
designed for conversions in electrochemistry−MS applica-
tions.50 Their cell is based on thin gold wires, wound around a
50-μm-diameter stainless steel wire channel template cast in
PDMS. An ESI needle is also integrated into the total chip.
Using this cell, subsecond transfer times between the
electrochemical cell and the MS signal are reported. However,
the major drawback of this cell is the limited conversion
eﬃciency of 30% at a ﬂow rate of 0.5 μL/min for the oxidation
products of dopamine. Moreover, PDMS is not really suitable
for MS applications, since PDMS tends to adsorb ions and
swell if exposed to organic solvents such as the frequently used
acetonitrile.51
A miniaturized device for electrochemical conversions worth
mentioning is the device shown by Nissila and co-workers.52,53
The main operating principle of their device is based on the
photocatalytic properties of the TiO2 pillars present on their
device. Under the inﬂuence of ultraviolet (UV) light, an
Table 1. Reactions Known to be Catalyzed by CYP450,
Compared to the Reactions Observed Using Direct
Oxidation in Electrochemical Cells
Phase 1 reactions catalyzed by
CYP4509,11,16 reactions by direct oxidation
hydroxylation benzylic and aromatic
hydroxylation9
allylic/aliphatic hydroxylation10
N,O,S-dealkylation N,O-dealkylation9
dehydrogenation dehydrogenation19,21
N,S,P-oxidation N,S,P-oxidation9,16
epoxidation
alcohol and aldehyde oxidation
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oxidizing potential becomes available to oxidize products
present in the electrolyte between the pillars. The device also
has an integrated ESI needle. Electrical forces pull on the liquid
cone at the ESI tip, generating a spray. Therefore, the ESI
needle drives the liquid through the pillars into the MS. This
device is used to mimic the oxidative metabolism of Verapamil,
which is a known calcium channel blocker used as
antiarrhythmic drug. The major drawback of this approach is
that the potential and currents used for the oxidation cannot be
determined precisely.
In two previous papers, we show that it is feasible to use a
miniaturized integrated three-electrode electrochemical cell for
drug metabolism studies.33,54 One of the major diﬀerences that
sets our design apart from others is that a separate side channel
is used, containing the counter electrode to isolate the products
generated at the counter electrode and the working electrode.
The design of the chips is aimed at obtaining high conversion
rates of introduced compounds. The main disadvantage we
encountered was the high ohmic drop, which especially gave
problems at higher ﬂow rates as the current increased. In the
previous studies, a sample loop was used to collect reaction
products, because direct coupling to the MS was not possible,
because of ﬂow rate mismatches between the chip and the MS.
In this paper, we present a novel cell design with frit channels
to reduce the ohmic drop. We show that by addition of these
channels, the performance is increased signiﬁcantly. Moreover,
two ﬂuidic ﬂow resistors are added to the two channels
containing the working and counter electrode to establish a
well-deﬁned ﬂow ratio without the use of an extra syringe
pump. For the ﬁrst time, we use this new chip design with
direct online microchip ESI to study the conversion of
mitoxantrone, which is an intercalating antitumor agent.
■ EXPERIMENTAL SECTION
Chip Fabrication. The chip designs used in this paper are
shown in Figure 1. It consists of two glass substrates, processed
by standard photolithography, sputtering, wet-etching, and
powder-blasting techniques. Fabrication of this chip is out-
sourced to Micronit (Micronit Microﬂuidics BV, The Nether-
lands). The geometry of channels and electrodes is optimized
for high conversion rates of introduced compounds, following
the same calculations as those published in a previous paper.54
On each chip, a ﬂuidic inlet is visible on the right. A platinum
pseudo-reference is placed upstream next to the inlet. Left of
the pseudo-reference, the ﬂow splits into two equal parts
through two main microﬂuidic channels. Each channel contains
either the platinum working electrode or the counter electrode.
The outlet of the working electrode channel is connected to
external equipment like the ESI interface of the MS. In our
previous work, we used a second syringe pump in withdrawal
mode to control the ﬂow over the counter electrode, but this
additional pump was not required using this new design, as
explained below. Two diﬀerent chips were made. One design
(B) contains small connecting channels between both main
channels, which act as a sort of porous frit to conduct the
current from faradaic reactions that are taking place at the
electrodes. The other design (A) did not include these frit
channels to be able to compare this new design to our previous
work,33,54 which did not include these frit channels.
In the design with frit channels, the end of each main
channel, just before the outlet, is terminated with a microﬂuidic
ﬂow resistor. These two ﬂow resistors are added to make sure
that the ﬂow velocity is indeed split into two equal parts,
regardless of small diﬀerences in ﬂuidic resistance caused by
tubing and additional equipment connected to the outlets of
the chip. In the no-frit design, these ﬂow resistors are included
directly after the T-junction, where the ﬂow is split to prevent
products generated at the working electrode to diﬀuse back to
the pseudo-reference electrode at low ﬂow rates. The working
electrode is also present at the bottom of the ﬂow resistor in the
no-frit design.
The main channels in both chip designs have a cross-
sectional area of 5 μm × 500 μm. The length of the two side
channels is 30 mm, whereas the electrodes cover the entire
width of the bottom of the main channels with a total length of
24 mm. The perpendicular frit channels have a cross-sectional
area of 5 μm × 100 μm and are 9.4 mm in length. The length of
the frit channels is chosen such that it takes hours for products
generated at the counter electrode to diﬀuse to the working
electrode, assuming there is no ﬂow (convection) in the frit
channels. The total volume inside the chip is ∼175 nL.
Chemicals. Cyclic voltammetry results were obtained using
a solution of 1 mM potassium ferrocyanide, 1 mM potassium
ferricyanide, and 0.1 M KNO3 as a supporting electrolyte.
Chronoamperometric measurements were conducted using a
solution of 0.42 mM potassium ferrocyanide, 0.42 mM
potassium ferricyanide, and 0.1 M KNO3. Mitoxantrone MS
measurements were conducted using a solution of 100 μM
mitoxantrone, 20 mM NH4HCO3 (>99.5% Fluka) supporting
electrolyte dissolved in 50/50/1 vol % water/acetonitrile
(>99.9% ABCR GmbH)/formic acid (>98% Merck). Sheath
Figure 1. Photograph and schematic drawing of the two designs of the
miniaturized three-electrode electrochemical cell without (A,C) and
with (B,D) frit channels. The main channels have a cross-sectional area
of 5 μm × 500 μm. The length of the two side channels is 30 mm,
whereas the platinum working electrode (WE) and counter (CE)
electrode cover the entire width of the bottom of the main channels,
with a total length of 24 mm. The platinum pseudo-reference electrode
(REF or RE) is placed at the bottom of the inlet channel and has
dimensions of 500 μm × 200 μm. The perpendicular frit channels have
a cross-sectional area of 5 μm × 100 μm and are 9.4 mm in length.
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ﬂow was supplied using a buﬀer solution of 50/50/1 vol %
water/methanol/acetic acid to get a more stable electrospray.
All chemicals are obtained from Sigma−Aldrich, unless
otherwise mentioned, and high-performance liquid chromatog-
raphy (HPLC)-grade solvents or deionized water (Milli-Q
water puriﬁcation system) are used to prepare the solutions.
Methods and Setup. In Figure 2, the overall setup is
indicated. The electrochemical chip was connected to a syringe
pump (Model 210, KD Scientiﬁc) using fused-silica tubing and
the Fluidic Connect 4515 chipholder from Micronit, which also
provides electrical connections by spring metal contact probes.
For the cyclic voltammetry and impedance experiments, a
Biologic SP-300 potentiostat (Bio-Logic SAS, France) was
used. Impedance measurements were conducted by recording a
Bode plot between 1 Hz and 1 MHz using a sine wave of 10
mV amplitude. Listed impedance values are determined from
the resistive plateau at 0° phase in the Bode plot, to make sure
that the impedance from the electrical double layer is not
included in the overall value. In MS and UV experiments, a
Palmsens (Palm Instruments B.V., The Netherlands) portable
potentiostat was used to apply ﬁxed potentials in chronoam-
perometric mode for 6 min.
For the conversion eﬃciency study, the working electrode
channel outlet of the chip was connected to an optical ﬂow-
through cell (type LPC-10MM, Ocean Optics) with an inner
volume of 2.4 μL. Optical absorbance measurements were
conducted using a MayaPro spectrometer (Ocean Optics) and
a deuterium light source (type DH-2000, Ocean Optics)
attenuated (type FVA-UV) to prevent saturation of the
spectrometer. Absorbance was determined by comparing the
absorbance of ferricyanide at 418 nm (extinction coeﬃcient =
1000 M−1 cm−1) and a reference wavelength of 500 nm where
no absorbance is observed.
For MS measurements, the working electrode channel of the
electrochemical chip was connected to an in-house-developed
microchip ESI. The details of this chip can be found
elsewhere.55 In short, it consists of a polyimide and a
polyethylene sheet laminated together. The polyimide sheet is
processed by laser ablation to provide microﬂuidic channels and
carbon ink is added to provide the electrode required to
transfer the high voltage to the liquid inside the ESI tip. The
channels of the ESI chip are 50 μm × 100 μM in size. A metal
connector with low dead volume was placed between the
electrochemical chip and the ESI chip, to provide electrical
grounding and decoupling of the two diﬀerent chips. Because a
conductive buﬀer was used to get a good conversion eﬃciency
in the electrochemical chip, a 35-cm-long piece of fused-silica
tubing with an inner diameter of 75 μm was placed between the
Figure 2. Schematic overview of the setup used for the drug metabolism studies. A syringe pump introduces analyte into the electrochemical chip.
Electrode potentials are controlled by a Palmsens potentiostat. The outlet of the working electrode channel is connected to the microchip ESI using
a grounded metal union and a 35-cm-long piece of fused-silica tubing with an inner diameter of 75 μm to provide suﬃcient electrical resistance.
Figure 3. Cyclic voltammetry measurements of the chip design (a) without frit channels and (b) with frit channels in a solution of 1 mM/1 mM
ferrocyanide/ferricyanide and 0.1 M KNO3 at a scan rate of 40 mV/s at ﬂow rates of 0 μL/min (red), 0.5 μL/min (blue) 1.0 μL/min (pink), and 3.0
μL/min (green). The schematic picture of both chip types indicates resistance measurements between the three electrodes. Note the diﬀerence in
current range between panel (a) and panel (b).
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grounded connector and the ESI chip, to provide suﬃcient
electrical resistance such that no gas bubbles were formed by
water electrolysis at the ESI electrode. To ensure that the ﬂow
over both the working electrode and the counter electrode
channel remained equal, an equally long piece of tubing with
same diameter was connected to the counter electrode channel.
During the metabolism studies, an LTQ mass spectrometer
(Thermo Scientiﬁc) was used. A sheath ﬂow of 50/50/1 vol %
water/methanol/acetic acid was infused via the ESI chip under
various ﬂow rates to adjust the pH of sample solution and the
surface tension of solvent for good ESI performance.
Safety Considerations. Special care is required to prevent
the hazard of electric shock from the high voltage applied to the
ESI chip. Be sure to ground the liquid, to isolate the ESI part
from the rest of the system, e.g., using a grounded metal
connector between the fused-silica tubing.
■ RESULTS AND DISCUSSION
Electrochemical Chip Characterization. Figure 3 shows
cyclic voltammetry (CV) results measured in 1 mM/1 mM
ferrocyanide/ferricyanide and 0.1 M KNO3 at various ﬂow rates
for both chip designs without frit (Figure 3a) and with frit
(Figure 3b). The CV diagrams of the chips with frit (Figure 3b)
correspond to that of a reversible redox couple in the presence
of a controlled diﬀusion layer thickness, as illustrated by the
steady-state current after the peak. The microﬂuidic channel is
only 5 μm in height, which is depleted within milliseconds. On
the seconds time scale, this depletion will not be visible in the
diagram. However, at low ﬂow rates, depletion eﬀects are
clearly visible in the diagram by the lower current at maximum
voltages, compared to the peak current at ∼0.15 V. Most of this
diﬀusive behavior is caused by ions diﬀusing from the frit
channels to the electrodes. At higher ﬂow rates, convection
becomes the most dominant transport mechanism. This results
in higher peak currents and a shape that is similar to the CV
diagrams observed using the rotating (ring)-disk electrode
technique. Higher ﬂows lead to higher currents, which,
combined with the ohmic drop, results in increased peak
separation. Ohmic drop is usually referenced in the literature as
the uncompensated electrolyte resistance between the working
electrode and the reference electrode.56
The insets of Figure 3 indicate impedance measurements
between the three electrodes of both chip types. In the case of
the chip with frit channels, the electrolyte resistance between
the working electrode and the reference electrode is 420 kΩ,
that between the counter electrode and the reference electrode
is 850 kΩ, and that between the working electrode and the
counter electrode is 530 kΩ. The frit channels clearly oﬀer a
less-resistive path between the working electrode and the
counter electrode. As a result, less current is ﬂowing through
the channel between the working electrode and the reference
electrode, eﬀectively reducing ohmic drop. This chip layout can
be simpliﬁed to an equivalent electronic network of a resistor of
530 kΩ in parallel to two resistors of 420 kΩ and 850 kΩ in
series, connected to a current source. The resulting potential
drop over the 420-kΩ resistor at 8 μA is 1 V. The peak
separation observed at a ﬂow rate of 3 μL/min is 0.8 V. The
ohmic drop, in practice, is smaller, compared to the predicted
drop from the electronic network calculations, which we believe
is caused by the use of an oversimpliﬁed network model.
The curves obtained from the chips without frit (Figure 3a)
show mostly ohmic behavior, meaning that there is a clear slope
observed in the curves. Also, a small amount of hysteresis is
observed, indicating that some faradaic reactions are occurring.
Moreover, peak currents are not increasing at ﬂow rates above
0.25 μL/min, indicating that not all ferrocyanide is converted
inside the working electrode channel. From the ﬁelds of
electroplating and neuronal stimulation, it is already well-
known that nonuniform current densities lead to hot spots or
only parts of the total electrode surface participating in the
faradaic reactions.57−59 We believe that the slope observed in
cyclic voltammetry diagrams of the no-frit chip are caused by a
nonuniform current density over the working electrode. In
general, a certain overpotential must exist between the ions in
the solution and the electrode to drive the faradaic reactions. At
increasing potentials, a larger area of the working electrode has
suﬃcient overpotential to convert ions, which is linearly related
to the resistance of the electrolyte over the working electrode.
In contrast to the explanation of the ohmic drop given for the
Figure 4. (c,d) Chronoamperometric and (a,b) optical absorbance measurements of the chip design without frit channels (panels (a) and (c)) and
with frit channels (panels (b) and (d)) in a solution of 0.42 mM/0.42 mM ferrocyanide/ferricyanide and 0.1 M KNO3 at various ﬂow rates.
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frit chips, the ohmic behavior of the no-frit chip cannot directly
be explained by the (AC) impedance measurement between
the working electrode and the reference electrode. The actual
resistance between these two electrodes is diﬀerent during
conversion, because of the inhomogeneous current density,
especially inside the ﬂow resistor of the working electrode
channel.
Figure 4 shows current and optical absorbance measure-
ments in time at varied ﬂow, while a constant potential of either
0.5 V or −0.5 V is applied to the no-frit chips (Figures 4a and
4c) and frit chips (Figures 4b and 4d). Theoretically, the
current (i) can be calculated using the following formula:
=i QCF
where Q is the ﬂow rate over the working electrode (recorded
in units of L/s), C the bulk concentration of converted species
(given in units of mol/L), and F the Faraday constant (given in
units of coulomb/mol). The conversion eﬃciency can be
calculated by dividing the measured current over the theoretical
current. For each ﬂow rate, this eﬃciency is calculated and
listed in Figures 4c and 4d. The ﬂow rates listed in the ﬁgure
are the ﬂow rates as delivered by the syringe pump. The ﬂow
rate over the working electrode is half of that value. Analyte
solution from the outlets is collected and weighted to make
sure that this is indeed the case. The eﬃciencies reported in
Figures 4a and 4b are calculated using the following formula:
= −A A
A
Eff meas init
init
where Ainit is the initial absorbance (0.42 AU) and Ameas the
measured value at the point where the value is listed in the
ﬁgure.
For the frit chips, signiﬁcantly higher currents are measured
than expected for the conversion of ferricyanide to ferrocyanide
alone. Apparently, other reactions take place at the electrode as
well, eﬀectively increasing the measured current. The reduction
of protons to hydrogen is the most likely candidate for the
added reduction currents, because the electrolyte does not
contain a pH buﬀer. At oxidative potentials, it is more diﬃcult
to identify an added reaction taking place, besides the oxidation
of ferrocyanide to ferricyanide. Based on the applied potential
of 0.5 V, we expect that oxidation of water to oxygen gas is not
yet taking place. The optical measurements conﬁrm that, in
fact, all ferricyanide or ferrocyanide is totally converted up to a
ﬂow rate of 8 μL/min. The total conversion of ferricyanide is
observed at even higher ﬂow rates, up to 16 μL/min in some
experiments; however, generally, leakages were observed at
some point, because the pressure in the microﬂuidic system
becomes too high above 8 μL/min for reliable operation.
For the no-frit chips, conversion eﬃciencies reported from
the current measurements show good agreement with the
conversion eﬃciencies reported from the optical measurements.
Clearly, the limited current due to the high resistance of the
microﬂuidic channels limits the amount of ions that can be
converted inside the chip. Approximately 50% of the
ferricyanide is converted at 0.5 μL/min. At twice the ﬂow
rate (1 μL/min), half of the conversion eﬃciency (25%) is
reported. Based on that observation, it can be extrapolated that
total conversion of ions is only possible at ﬂow rates below 0.25
μL/min for the no-frit chip.
Metabolism of Mitoxantrone. Mitoxantrone (MX) is an
intercalating antitumor agent that is used in the treatment of
leukemia and other cancer types. It is known to have toxic
eﬀects and forms reactive intermediates. As already shown in a
paper by Lohmann and Karst,21 MX (m/z 445) can be oxidized
at 300 mV, resulting in the formation of a quinone (MXQ, m/z
443) and a quinone diimine (MXQQDI, m/z 441). At higher
voltages, products at m/z 457 and 473 also are observed, which
can be explained by the introduction of one or two O atoms
into the molecule. The reaction mechanism is shown in Scheme
1.
Figure 5 shows mass spectra measured with potentials of 0 V
(Figure 5a), 300 mV (Figure 5b), and 700 mV (Figure 5c)
applied to the working electrode at a ﬂow rate of 1.5 μL/min
through the chip and an added sheath ﬂow of 0.5 μL/min
inside the ESI chip. The employment of sheath ﬂow is
important to maintain good ESI performance when a
supporting electrolyte is used in the electrochemical chip. At
0 V, a small amount of oxidative products is already observed,
which probably results from the ESI interface. A clear increase
of the quinone product (MXQ, m/z 443) and a decrease of the
starting product MX (m/z 445) is observed at 300 mV. At 700
mV, the amount of MX is decreased further, resulting in
increased amounts of the quinone and quinone diimine
products. Also, the products at m/z 457 and 473 are observed
at this potential.
Mass traces recorded at 700 mV are shown in Figure 6a and
clearly indicate the decrease of the starting product MX and the
increase of the reaction products MXQ and MXQQDI during
the 6 min of applied oxidative potential. The dead volume of
Scheme 1. Oxidative Reaction Mechanism of Mitoxantrone
(MX) into a Quinone (MXQ, m/z 443) and a Quinone
Diimine (MXQQDI, m/z 441)
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ﬂuidic connectors and tubing result in a delay of ∼1.7 min at
the used ﬂow rate of 1.5 μL/min. Figure 6b shows the recorded
current during oxidation of MX. The current never reaches a
stable value, although clear plateaus are visible in the recorded
mass traces.
Overall, the shapes of these mass spectra are almost identical
to the results published earlier by Lohmann and Karst,21 using a
model 5020 macroscale-sized guard cell containing a porous
glassy carbon working electrode from ESA Biosciences, Inc.
(Chelmsford, MA) at a much higher ﬂow rate of 50 μL/min.
Therefore, it can be concluded that the chip shows similar
performance, while using less reagents.
■ CONCLUSION
In this paper, a novel chip design is discussed with two new
design aspects. Connecting frit channels between the main
channels containing either a working electrode or a counter
electrode provide a path to conduct current and decrease ohmic
drop. Flow restrictors reduce the need for an extra syringe
pump to control the ﬂow over each side channel. Overall
conversion eﬃciencies are clearly improved by the frit channels,
even at higher ﬂow rates than reported earlier,33,54 while
maintaining similar internal chip volumes. Moreover, ﬂow
resistors are introduced inside each side channel to maintain
equal ﬂows.
Cyclic voltammetry (CV) measurements recorded using
these new chips show less ohmic drop features, thereby
explaining the previously reported CV diagrams54 by a high
resistivity between the working electrode and the counter
electrode.
Chronoamperometry and optical absorbance measurements
at various ﬂow rates show good performance, up to at least 8
μL/min for the chips with frit channels. The chips without frit
channels show only moderate conversion at relatively low ﬂow
rates below 2 μL/min. Using the improved chip design, the
oxidative metabolism of mitoxantrone is studied. The chip is
able to generate all known oxidative products. Overall
conversion rates in drug oxidation are close to 100%, which
is almost identical to results previously reported in the
literature21 using large scale cells, while the novel chip requires
a ﬂow of reagents that is more than a factor 30 lower.
This work opens the way for the design of new chips
integrating both the miniaturized electrochemical cell and
electrospray in a single chip.
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